At the heart of SomaLogic’s unique technology platform are SOMAmer™ (Slow Off-rate Modified Aptamer) modified nucleic acid-based protein binding reagents, each of which are highly specific for their cognate protein.
To date, we have developed SOMAmers to a broad array of over 1000 different protein targets critical to normal and disease biology, and continue to add new SOMAmers to our list (see below), increasingly building the unparallelled power of our protein identification and measurement SOMAscanTM technology.